177 related articles for article (PubMed ID: 22776106)
1. Intravenous immunoglobulin treatment of the post-polio syndrome: sustained effects on quality of life variables and cytokine expression after one year follow up.
Gonzalez H; Khademi M; Borg K; Olsson T
J Neuroinflammation; 2012 Jul; 9():167. PubMed ID: 22776106
[TBL] [Abstract][Full Text] [Related]
2. Prior poliomyelitis-IVIg treatment reduces proinflammatory cytokine production.
Gonzalez H; Khademi M; Andersson M; Piehl F; Wallström E; Borg K; Olsson T
J Neuroimmunol; 2004 May; 150(1-2):139-44. PubMed ID: 15081258
[TBL] [Abstract][Full Text] [Related]
3. Post-polio syndrome patients treated with intravenous immunoglobulin: a double-blinded randomized controlled pilot study.
Farbu E; Rekand T; Vik-Mo E; Lygren H; Gilhus NE; Aarli JA
Eur J Neurol; 2007 Jan; 14(1):60-5. PubMed ID: 17222115
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial of IV immunoglobulin in patients with postpolio syndrome.
Bertolasi L; Frasson E; Turri M; Gajofatto A; Bordignon M; Zanolin E; Martini M; Pimazzoni F; Ferlisi M; Zanusso G; Rossi M; Monaco S
J Neurol Sci; 2013 Jul; 330(1-2):94-9. PubMed ID: 23683859
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin for post-polio syndrome: a randomised controlled trial.
Gonzalez H; Sunnerhagen KS; Sjöberg I; Kaponides G; Olsson T; Borg K
Lancet Neurol; 2006 Jun; 5(6):493-500. PubMed ID: 16713921
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin for postpolio syndrome: a systematic review and meta-analysis.
Huang YH; Chen HC; Huang KW; Chen PC; Hu CJ; Tsai CP; Tam KW; Kuan YC
BMC Neurol; 2015 Mar; 15():39. PubMed ID: 25886512
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Intravenous Immunoglobulin for Management of Pain in Patients with Postpolio Syndrome.
Chang MC; Park JS; Hwang JM; Park D
Pain Res Manag; 2021; 2021():6637705. PubMed ID: 33824690
[TBL] [Abstract][Full Text] [Related]
8. IVIG treatment in post-polio patients: evaluation of responders.
Ostlund G; Broman L; Werhagen L; Borg K
J Neurol; 2012 Dec; 259(12):2571-8. PubMed ID: 22592288
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages.
Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U
Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537
[TBL] [Abstract][Full Text] [Related]
10. Effect of intravenous immunoglobulin in patients with post-polio syndrome -- an uncontrolled pilot study.
Kaponides G; Gonzalez H; Olsson T; Borg K
J Rehabil Med; 2006 Mar; 38(2):138-40. PubMed ID: 16546773
[TBL] [Abstract][Full Text] [Related]
11. Effect of intravenous immunoglobulin on pain in patients with post-polio syndrome.
Werhagen L; Borg K
J Rehabil Med; 2011 Nov; 43(11):1038-40. PubMed ID: 22031351
[TBL] [Abstract][Full Text] [Related]
12. [Alteration of cytokines in serum and cerebrospinal fluid before and after high-dose immunoglobulin therapy in patients with West syndrome].
Matsuura R; Hamano SI; Hirata Y; Oba A; Kumagai Y; Suzuki K; Koichihara R; Kikuchi K; Tanaka M; Minamitani M
No To Hattatsu; 2016 Jul; 48(4):247-51. PubMed ID: 30010305
[TBL] [Abstract][Full Text] [Related]
13. Prior poliomyelitis-evidence of cytokine production in the central nervous system.
Gonzalez H; Khademi M; Andersson M; Wallström E; Borg K; Olsson T
J Neurol Sci; 2002 Dec; 205(1):9-13. PubMed ID: 12409177
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulin preparation attenuates LPS-induced production of pro-inflammatory cytokines in human monocytic cells by modulating TLR4-mediated signaling pathways.
Murakami K; Suzuki C; Kobayashi F; Nakano A; Fujii A; Sakai K; Imada T
Naunyn Schmiedebergs Arch Pharmacol; 2012 Sep; 385(9):891-8. PubMed ID: 22644107
[TBL] [Abstract][Full Text] [Related]
15. Treatment with L-citrulline in patients with post-polio syndrome: study protocol for a single-center, randomised, placebo-controlled, double-blind trial.
Schmidt S; Gocheva V; Zumbrunn T; Rubino-Nacht D; Bonati U; Fischer D; Hafner P
Trials; 2017 Mar; 18(1):116. PubMed ID: 28274276
[TBL] [Abstract][Full Text] [Related]
16. Modulation of immunoglobulin production and cytokine mRNA expression in peripheral blood mononuclear cells by intravenous immunoglobulin.
Toyoda M; Zhang X; Petrosian A; Galera OA; Wang SJ; Jordan SC
J Clin Immunol; 1994 May; 14(3):178-89. PubMed ID: 7523434
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin treatment in post-polio syndrome: Identification of responders and non-responders.
Östlund G; Broman L; Werhagen L; Borg K
J Rehabil Med; 2015 Sep; 47(8):727-33. PubMed ID: 26286895
[TBL] [Abstract][Full Text] [Related]
18. Post-polio syndrome is not a dysimmune condition.
Laffont I; Duflos C; Hirtz C; Bakhti K; Gelis A; Palayer C; Macioce V; Soler M; Pradalier F; Galtier F; Jentzer A; Lozano C; Vincent T; Morales RJ
Eur J Phys Rehabil Med; 2024 Apr; 60(2):270-279. PubMed ID: 38252127
[TBL] [Abstract][Full Text] [Related]
19. Effect of treatment with intravenous immunoglobulin on quality of life in patients with stiff-person syndrome.
Gerschlager W; Brown P
Mov Disord; 2002 May; 17(3):590-3. PubMed ID: 12112212
[TBL] [Abstract][Full Text] [Related]
20. High-Dose Intravenous Immunoglobulin Is Effective in Painful Diabetic Polyneuropathy Resistant to Conventional Treatments. Results of a Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial.
Jann S; Fazio R; Cocito D; Toscano A; Schenone A; Marfia GA; Antonini G; De Toni Franceschini L; Mazzeo A; Grandis M; Velardo D; Mataluni G; Peci E
Pain Med; 2020 Mar; 21(3):576-585. PubMed ID: 31904855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
